<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Peptomiq Lab Notes</title>
    <link>https://www.peptomiq.com/lab-notes</link>
    <atom:link href="https://www.peptomiq.com/rss.xml" rel="self" type="application/rss+xml" />
    <description>Peptide vendor purity audits, study summaries and analytical methods from the Peptomiq science team.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 01 May 2026 15:19:32 GMT</lastBuildDate>
    <item>
      <title>TB-500 Vendor Purity Audit: 10 Suppliers Compared by HPLC (Q2 2026)</title>
      <link>https://www.peptomiq.com/lab-notes/tb-500-vendor-purity-audit-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/tb-500-vendor-purity-audit-2026</guid>
      <description>We assayed TB-500 from 10 research-peptide vendors by RP-HPLC and LC-MS. Six passed &gt;97% purity, two were truncated fragments, one was thymosin beta-4 1-44 only.</description>
      <pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate>
      <category>TB-500</category>
      <category>thymosin beta-4</category>
      <category>vendor purity</category>
      <category>HPLC</category>
      <category>LC-MS</category>
      <category>quality control</category>
      <category>Vendor Tests</category>
    </item>
    <item>
      <title>How We Test Peptide Purity: Our RP-HPLC + LC-MS Methodology (2026 Edition)</title>
      <link>https://www.peptomiq.com/lab-notes/how-we-test-peptide-purity-hplc-ms-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/how-we-test-peptide-purity-hplc-ms-2026</guid>
      <description>A transparent walk-through of the column, gradient, detector and mass-spec settings we use to verify research-peptide purity to 0.1% — and what numbers on a COA actually mean.</description>
      <pubDate>Tue, 28 Apr 2026 00:00:00 GMT</pubDate>
      <category>HPLC</category>
      <category>LC-MS</category>
      <category>purity testing</category>
      <category>methodology</category>
      <category>certificate of analysis</category>
      <category>quality control</category>
      <category>Methods</category>
    </item>
    <item>
      <title>Semaglutide vs Tirzepatide: Receptor Pharmacology Side-by-Side</title>
      <link>https://www.peptomiq.com/lab-notes/semaglutide-vs-tirzepatide-receptor-pharmacology-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/semaglutide-vs-tirzepatide-receptor-pharmacology-2026</guid>
      <description>GLP-1 mono-agonism vs dual GLP-1/GIP agonism — receptor binding affinities, downstream signaling differences, and what the head-to-head SURMOUNT-5 data does and doesn&apos;t tell us.</description>
      <pubDate>Sat, 18 Apr 2026 00:00:00 GMT</pubDate>
      <category>semaglutide</category>
      <category>tirzepatide</category>
      <category>GLP-1</category>
      <category>GIP</category>
      <category>incretin</category>
      <category>receptor pharmacology</category>
      <category>Study Summary</category>
    </item>
    <item>
      <title>Endotoxin Testing for Research Peptides: LAL vs Recombinant Factor C</title>
      <link>https://www.peptomiq.com/lab-notes/endotoxin-testing-lal-vs-rfc-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/endotoxin-testing-lal-vs-rfc-2026</guid>
      <description>How we screen every Peptomiq lot for endotoxin contamination — the LAL kinetic-chromogenic assay, why we cross-check with recombinant Factor C, and the EU/USP limits we hold to.</description>
      <pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate>
      <category>endotoxin</category>
      <category>LAL</category>
      <category>rFC</category>
      <category>quality control</category>
      <category>USP</category>
      <category>methods</category>
      <category>Methods</category>
    </item>
    <item>
      <title>Ipamorelin + CJC-1295 (DAC): Why the Stack Works on Receptor Math</title>
      <link>https://www.peptomiq.com/lab-notes/ipamorelin-vs-cjc-1295-stack-pharmacology-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/ipamorelin-vs-cjc-1295-stack-pharmacology-2026</guid>
      <description>Ipamorelin is a ghrelin-mimetic; CJC-1295 with DAC is a long-acting GHRH analog. We walk through the two-receptor synergy, half-life mismatch, and what the rodent pulse-amplitude data shows.</description>
      <pubDate>Fri, 10 Apr 2026 00:00:00 GMT</pubDate>
      <category>ipamorelin</category>
      <category>CJC-1295</category>
      <category>GHRH</category>
      <category>ghrelin</category>
      <category>growth hormone</category>
      <category>stack</category>
      <category>Study Summary</category>
    </item>
    <item>
      <title>BPC-157 in Achilles Tendon Repair: A 2024 Rat-Model Study Summary</title>
      <link>https://www.peptomiq.com/lab-notes/bpc-157-tendon-healing-study-summary-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/bpc-157-tendon-healing-study-summary-2026</guid>
      <description>Plain-English summary of a 2024 rat Achilles-transection study showing accelerated collagen organization with BPC-157 — endpoints, dosing schedule, controls and what the data does and doesn&apos;t show.</description>
      <pubDate>Tue, 28 Apr 2026 00:00:00 GMT</pubDate>
      <category>BPC-157</category>
      <category>tendon repair</category>
      <category>tissue repair</category>
      <category>rat model</category>
      <category>study summary</category>
      <category>collagen</category>
      <category>Study Summary</category>
    </item>
    <item>
      <title>Epitalon and Telomere Length: What 25 Years of Research Actually Shows</title>
      <link>https://www.peptomiq.com/lab-notes/epitalon-telomere-research-summary-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/epitalon-telomere-research-summary-2026</guid>
      <description>A critical summary of the Khavinson telomere literature on Epitalon — what telomerase activation has been measured in vitro, the 12-year human cohort claims, and the replication gaps.</description>
      <pubDate>Sat, 04 Apr 2026 00:00:00 GMT</pubDate>
      <category>epitalon</category>
      <category>telomerase</category>
      <category>longevity</category>
      <category>Khavinson</category>
      <category>study summary</category>
      <category>Study Summary</category>
    </item>
    <item>
      <title>Reconstituted Peptide Stability: How Long Does It Actually Last in BAC Water?</title>
      <link>https://www.peptomiq.com/lab-notes/peptide-reconstitution-bacteriostatic-water-stability-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/peptide-reconstitution-bacteriostatic-water-stability-2026</guid>
      <description>We ran a 60-day stability study on six common research peptides reconstituted in 0.9% benzyl-alcohol bacteriostatic water. Degradation curves, refrigeration impact, and which peptides die first.</description>
      <pubDate>Sat, 28 Mar 2026 00:00:00 GMT</pubDate>
      <category>reconstitution</category>
      <category>stability</category>
      <category>bacteriostatic water</category>
      <category>BPC-157</category>
      <category>ipamorelin</category>
      <category>methods</category>
      <category>Methods</category>
    </item>
    <item>
      <title>MOTS-c and Mitochondrial Function: A Plain-English Research Summary</title>
      <link>https://www.peptomiq.com/lab-notes/mots-c-mitochondrial-research-summary-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/mots-c-mitochondrial-research-summary-2026</guid>
      <description>MOTS-c is a 16-aa mitochondrial-derived peptide that activates AMPK. We summarize the rodent metabolic data, the human exercise-cohort observations, and what the AMPK pathway means in practice.</description>
      <pubDate>Sun, 22 Mar 2026 00:00:00 GMT</pubDate>
      <category>MOTS-c</category>
      <category>mitochondrial</category>
      <category>AMPK</category>
      <category>metabolic health</category>
      <category>longevity</category>
      <category>Study Summary</category>
    </item>
    <item>
      <title>Selank vs Semax: Two Russian Nootropic Peptides Compared</title>
      <link>https://www.peptomiq.com/lab-notes/selank-vs-semax-cognitive-research-comparison-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/selank-vs-semax-cognitive-research-comparison-2026</guid>
      <description>Selank is an anxiolytic tuftsin analog; Semax is an ACTH 4-10 fragment with BDNF-upregulating effects. Side-by-side mechanism, intranasal pharmacokinetics, and the rodent behavioral data.</description>
      <pubDate>Sun, 15 Mar 2026 00:00:00 GMT</pubDate>
      <category>selank</category>
      <category>semax</category>
      <category>nootropic</category>
      <category>BDNF</category>
      <category>anxiolytic</category>
      <category>intranasal</category>
      <category>Study Summary</category>
    </item>
    <item>
      <title>BPC-157 Vendor Purity Audit: 12 Suppliers Tested by HPLC (Q1 2026)</title>
      <link>https://www.peptomiq.com/lab-notes/bpc-157-vendor-purity-audit-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/bpc-157-vendor-purity-audit-2026</guid>
      <description>We assayed BPC-157 from 12 research-peptide vendors by reverse-phase HPLC. Eight passed &gt;97%, three failed below 90%, one was undetectable. Full results inside.</description>
      <pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate>
      <category>BPC-157</category>
      <category>vendor purity</category>
      <category>HPLC</category>
      <category>research peptides</category>
      <category>quality control</category>
      <category>Vendor Tests</category>
    </item>
    <item>
      <title>GHK-Cu in Skin Research: Collagen Synthesis, Wound Healing and the Copper Question</title>
      <link>https://www.peptomiq.com/lab-notes/ghk-cu-skin-research-summary-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/ghk-cu-skin-research-summary-2026</guid>
      <description>GHK-Cu is a copper-binding tripeptide implicated in collagen, elastin and decorin synthesis. We summarize the in-vitro fibroblast data, the topical wound-healing trials, and the copper-toxicity ceiling.</description>
      <pubDate>Sun, 08 Mar 2026 00:00:00 GMT</pubDate>
      <category>GHK-Cu</category>
      <category>copper peptide</category>
      <category>collagen</category>
      <category>wound healing</category>
      <category>skin research</category>
      <category>Study Summary</category>
    </item>
    <item>
      <title>Semaglutide vs Tirzepatide vs Retatrutide: How the Three Compounds Actually Differ</title>
      <link>https://www.peptomiq.com/lab-notes/glp1-class-comparison-2026</link>
      <guid isPermaLink="true">https://www.peptomiq.com/lab-notes/glp1-class-comparison-2026</guid>
      <description>A research-context summary of the GLP-1, GIP and glucagon receptor activity profiles for semaglutide, tirzepatide and retatrutide. With half-lives, study endpoints and citation pointers.</description>
      <pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate>
      <category>semaglutide</category>
      <category>tirzepatide</category>
      <category>retatrutide</category>
      <category>GLP-1</category>
      <category>GIP</category>
      <category>incretin research</category>
      <category>Study Summary</category>
    </item>
  </channel>
</rss>
